Aleksander Tworak
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Aleksander Tworak has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
- Jan Podkowiński
Department of Genomics, Institute of Bioorganic Chemistry, Polish Academy of Sciences, 61-704 Poznan, Poland
4 shared publications - Krzysztof Palczewski
Department of Ophthalmology and Visual Sciences, Gavin Herbert Eye Institute—Brunson Center for Translational Vision Research University of California Irvine Irvine California USA
4 shared publications - Anna Urbanowicz
Institute of Bioorganic Chemistry, Polish Academy of Sciences, 61-704 Poznań, Poland
3 shared publications - Anna Kurzynska-Kokorniak
Department of Ribonucleoprotein Biochemistry, Institute of Bioorganic Chemistry Polish Academy of Sciences, Poznan, Poland
2 shared publications - Henri Leinonen
School of Pharmacy, University of Eastern Finland, Kuopio, Finland
2 shared publications Marek Figlerowicz
2 shared publications
Latest Publications
- Open Access
- 25 August 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-17
Structural basis for the allosteric modulation of rhodopsin by nanobody binding to its extracellular domain
Rhodopsin is a prototypical G protein-coupled receptor (GPCR) critical for vertebrate vision. Research on GPCR signaling states has been facilitated using llama-derived nanobodies (Nbs), some of which bind to the intracellular surface to allosterically modulate the receptor. Extracellularly binding allosteric nanobodies have also been investigated, but the structural basis for their activity has not been resolved to date. Here, we report a library of Nbs that bind to the extracellular surface of rhodopsin and allosterically modulate the thermodynamics of its activation process. Crystal structures of Nb2 in complex with native rhodopsin reveal a mechanism of allosteric modulation involving extracellular loop 2 and native glycans. Nb2 binding suppresses Schiff base deprotonation and hydrolysis and prevents intracellular outward movement of helices five and six – a universal activation event for GPCRs. Nb2 also mitigates protein misfolding in a disease-associated mutant rhodopsin. Our data show the power of nanobodies to modulate the photoactivation of rhodopsin and potentially serve as therapeutic agents for disease-associated rhodopsin misfolding.
- 25 August 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-17
Open AccessStructural basis for the allosteric modulation of rhodopsin by nanobody binding to its extracellular domain
Rhodopsin is a prototypical G protein-coupled receptor (GPCR) critical for vertebrate vision. Research on GPCR signaling states has been facilitated using llama-derived nanobodies (Nbs), some of which bind to the intracellular surface to allosterically modulate the receptor. Extracellularly binding allosteric nanobodies have also been investigated, but the structural basis for their activity has not been resolved to date. Here, we report a library of Nbs that bind to the extracellular surface of rhodopsin and allosterically modulate the thermodynamics of its activation process. Crystal structures of Nb2 in complex with native rhodopsin reveal a mechanism of allosteric modulation involving extracellular loop 2 and native glycans. Nb2 binding suppresses Schiff base deprotonation and hydrolysis and prevents intracellular outward movement of helices five and six – a universal activation event for GPCRs. Nb2 also mitigates protein misfolding in a disease-associated mutant rhodopsin. Our data show the power of nanobodies to modulate the photoactivation of rhodopsin and potentially serve as therapeutic agents for disease-associated rhodopsin misfolding.
- Open Access
- 22 February 2022
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 7 (4)
Inhibition of ceramide accumulation in AdipoR1–/– mice increases photoreceptor survival and improves vision
Adiponectin receptor 1 (ADIPOR1) is a lipid and glucose metabolism regulator that possesses intrinsic ceramidase activity. Mutations of the ADIPOR1 gene have been associated with nonsyndromic and syndromic retinitis pigmentosa. Here, we show that the absence of AdipoR1 in mice leads to progressive photoreceptor degeneration, significant reduction of electroretinogram amplitudes, decreased retinoid content in the retina, and reduced cone opsin expression. Single-cell RNA-Seq results indicate that ADIPOR1 encoded the most abundantly expressed ceramidase in mice and one of the 2 most highly expressed ceramidases in the human retina, next to acid ceramidase ASAH1 . We discovered an accumulation of ceramides in the AdipoR1 –/– retina, likely due to insufficient ceramidase activity for healthy retina function, resulting in photoreceptor death. Combined treatment with desipramine/L-cycloserine (DC) lowered ceramide levels and exerted a protective effect on photoreceptors in AdipoR1 –/– mice. Moreover, we observed improvement in cone-mediated retinal function in the DC-treated animals. Lastly, we found that prolonged DC treatment corrected the electrical responses of the primary visual cortex to visual stimuli, approaching near-normal levels for some parameters. These results highlight the importance of ADIPOR1 ceramidase in the retina and show that pharmacological inhibition of ceramide generation can provide a therapeutic strategy for ADIPOR1- related retinopathy.
- 22 February 2022
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 7 (4)
Open AccessInhibition of ceramide accumulation in AdipoR1–/– mice increases photoreceptor survival and improves vision
Adiponectin receptor 1 (ADIPOR1) is a lipid and glucose metabolism regulator that possesses intrinsic ceramidase activity. Mutations of the ADIPOR1 gene have been associated with nonsyndromic and syndromic retinitis pigmentosa. Here, we show that the absence of AdipoR1 in mice leads to progressive photoreceptor degeneration, significant reduction of electroretinogram amplitudes, decreased retinoid content in the retina, and reduced cone opsin expression. Single-cell RNA-Seq results indicate that ADIPOR1 encoded the most abundantly expressed ceramidase in mice and one of the 2 most highly expressed ceramidases in the human retina, next to acid ceramidase ASAH1 . We discovered an accumulation of ceramides in the AdipoR1 –/– retina, likely due to insufficient ceramidase activity for healthy retina function, resulting in photoreceptor death. Combined treatment with desipramine/L-cycloserine (DC) lowered ceramide levels and exerted a protective effect on photoreceptors in AdipoR1 –/– mice. Moreover, we observed improvement in cone-mediated retinal function in the DC-treated animals. Lastly, we found that prolonged DC treatment corrected the electrical responses of the primary visual cortex to visual stimuli, approaching near-normal levels for some parameters. These results highlight the importance of ADIPOR1 ceramidase in the retina and show that pharmacological inhibition of ceramide generation can provide a therapeutic strategy for ADIPOR1- related retinopathy.
- Open Access
- 1 December 2019
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 294 (50) , 19137-19154
Photic generation of 11-cis-retinal in bovine retinal pigment epithelium
- 1 December 2019
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 294 (50) , 19137-19154
Open AccessPhotic generation of 11-cis-retinal in bovine retinal pigment epithelium
- Open Access
- 1 December 2017
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 292 (48) , 19826-19839
Quantitative phosphoproteomics reveals involvement of multiple signaling pathways in early phagocytosis by the retinal pigmented epithelium
- 1 December 2017
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 292 (48) , 19826-19839
Open AccessQuantitative phosphoproteomics reveals involvement of multiple signaling pathways in early phagocytosis by the retinal pigmented epithelium
- Open Access
- 29 January 2016
- Published by Springer Nature in Plant Cell Reports
- Vol. 35 (5) , 1043-1052
Six Medicago truncatula Dicer-like protein genes are expressed in plant cells and upregulated in nodules
Key message Here we report the existence of six putative Dicer-like genes in the Medicago truncatula genome. They are ubiquitously expressed throughout the plant and significantly induced in root nodules. Abstract Over the past decade, small noncoding RNAs (sncRNA) have emerged as widespread and important regulatory molecules influencing both the structure and expression of plant genomes. One of the key factors involved in sncRNA biogenesis in plants is a group of RNase III-type nucleases known as Dicer-like (DCL) proteins. Based on functional analysis of DCL proteins identified in Arabidopsis thaliana, four types of DCLs were distinguished (DCL1-4). DCL1 mainly produces 21 nt miRNAs. The products generated by DCL2, DCL3, and DCL4 belong to various classes of siRNAs that are 22, 24 and 21 nt in length, respectively. M. truncatula is a model legume plant closely related to many economically important cultivable species. By screening the recent M. truncatula genome assembly, we were able to identify three new DCL genes in addition to the MtDCL1-3 genes that had been earlier characterized. The newly found genes include MtDCL4 and two MtDCL2 homologs. We showed that all six M. truncatula DCL genes are expressed in plant cells. The first of the identified MtDCL2 paralogs encodes a truncated version of the DCL2 protein, while the second undergoes substantial and specific upregulation in the root nodules. Additionally, we identified an alternative splicing variant of MtDCL1 mRNA, similar to the one found in Arabidopsis. Our results indicate that DCL genes are differently activated during Medicago symbiosis with nitrogen fixing bacteria and upon pathogen infection. In addition, we hypothesize that the alternative splicing variant of MtDCL1 mRNA may be involved in tissue-specific regulation of the DCL1 level.
- 29 January 2016
- Published by Springer Nature in Plant Cell Reports
- Vol. 35 (5) , 1043-1052
Open AccessSix Medicago truncatula Dicer-like protein genes are expressed in plant cells and upregulated in nodules
Key message Here we report the existence of six putative Dicer-like genes in the Medicago truncatula genome. They are ubiquitously expressed throughout the plant and significantly induced in root nodules. Abstract Over the past decade, small noncoding RNAs (sncRNA) have emerged as widespread and important regulatory molecules influencing both the structure and expression of plant genomes. One of the key factors involved in sncRNA biogenesis in plants is a group of RNase III-type nucleases known as Dicer-like (DCL) proteins. Based on functional analysis of DCL proteins identified in Arabidopsis thaliana, four types of DCLs were distinguished (DCL1-4). DCL1 mainly produces 21 nt miRNAs. The products generated by DCL2, DCL3, and DCL4 belong to various classes of siRNAs that are 22, 24 and 21 nt in length, respectively. M. truncatula is a model legume plant closely related to many economically important cultivable species. By screening the recent M. truncatula genome assembly, we were able to identify three new DCL genes in addition to the MtDCL1-3 genes that had been earlier characterized. The newly found genes include MtDCL4 and two MtDCL2 homologs. We showed that all six M. truncatula DCL genes are expressed in plant cells. The first of the identified MtDCL2 paralogs encodes a truncated version of the DCL2 protein, while the second undergoes substantial and specific upregulation in the root nodules. Additionally, we identified an alternative splicing variant of MtDCL1 mRNA, similar to the one found in Arabidopsis. Our results indicate that DCL genes are differently activated during Medicago symbiosis with nitrogen fixing bacteria and upon pathogen infection. In addition, we hypothesize that the alternative splicing variant of MtDCL1 mRNA may be involved in tissue-specific regulation of the DCL1 level.
- Open Access
- 16 April 2015
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 43 (9) , 4365-4380
The many faces of Dicer: the complexity of the mechanisms regulating Dicer gene expression and enzyme activities
There is increasing evidence indicating that the production of small regulatory RNAs is not the only process in which ribonuclease Dicer can participate. For example, it has been demonstrated that this enzyme is also involved in chromatin structure remodelling, inflammation and apoptotic DNA degradation. Moreover, it has become increasingly clear that cellular transcript and protein levels of Dicer must be strictly controlled because even small changes in their accumulation can initiate various pathological processes, including carcinogenesis. Accordingly, in recent years, a number of studies have been performed to identify the factors regulating Dicer gene expression and protein activity. As a result, a large amount of complex and often contradictory data has been generated. None of these data have been subjected to an exhaustive review or critical discussion. This review attempts to fill this gap by summarizing the current knowledge of factors that regulate Dicer gene transcription, primary transcript processing, mRNA translation and enzyme activity. Because of the high complexity of this topic, this review mainly concentrates on human Dicer. This review also focuses on an additional regulatory layer of Dicer activity involving the interactions of protein and RNA factors with Dicer substrates.
- 16 April 2015
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 43 (9) , 4365-4380
Open AccessThe many faces of Dicer: the complexity of the mechanisms regulating Dicer gene expression and enzyme activities
There is increasing evidence indicating that the production of small regulatory RNAs is not the only process in which ribonuclease Dicer can participate. For example, it has been demonstrated that this enzyme is also involved in chromatin structure remodelling, inflammation and apoptotic DNA degradation. Moreover, it has become increasingly clear that cellular transcript and protein levels of Dicer must be strictly controlled because even small changes in their accumulation can initiate various pathological processes, including carcinogenesis. Accordingly, in recent years, a number of studies have been performed to identify the factors regulating Dicer gene expression and protein activity. As a result, a large amount of complex and often contradictory data has been generated. None of these data have been subjected to an exhaustive review or critical discussion. This review attempts to fill this gap by summarizing the current knowledge of factors that regulate Dicer gene transcription, primary transcript processing, mRNA translation and enzyme activity. Because of the high complexity of this topic, this review mainly concentrates on human Dicer. This review also focuses on an additional regulatory layer of Dicer activity involving the interactions of protein and RNA factors with Dicer substrates.
- Open Access
- 1 January 2013
- Published by Termedia Sp. z.o.o. in BioTechnologia
- Vol. 94 (1) , 22-26
Animal Dicer and plant Dicer-like proteins
- 1 January 2013
- Published by Termedia Sp. z.o.o. in BioTechnologia
- Vol. 94 (1) , 22-26
Open AccessAnimal Dicer and plant Dicer-like proteins
- Open Access
- 1 January 2011
- Published by Termedia Sp. z.o.o. in BioTechnologia
- Vol. 92 (4) , 321-335
OPINIONSAcetyl-coenzyme A carboxylase – an attractive enzyme for biotechnology
Acetyl-CoA carboxylase catalyzes the carboxylation of acetyl-CoA to malonyl-CoA. This reaction constitutes the first committed step of fatty acid synthesis in most organisms, while its product also serves as a universal precursor for various other high-value compounds. The important regulatory and rate-limiting role of acetyl-CoA carboxylase makes this enzyme a powerful tool in a variety of biotechnological and medical projects. This review presents the current knowledge on structural and functional features of the enzyme and focuses on its divergent applications. Different metabolic engineering attempts that lead to the production of various compounds, such as fatty acids, polyketides or flavonoids, are presented and their advantages and limitations discussed. The importance of studies on acetyl-CoA carboxylase activity for design and development of new herbicides and antibiotics as well as for medical intervention is also highlighted.
- 1 January 2011
- Published by Termedia Sp. z.o.o. in BioTechnologia
- Vol. 92 (4) , 321-335
Open AccessOPINIONSAcetyl-coenzyme A carboxylase – an attractive enzyme for biotechnology
Acetyl-CoA carboxylase catalyzes the carboxylation of acetyl-CoA to malonyl-CoA. This reaction constitutes the first committed step of fatty acid synthesis in most organisms, while its product also serves as a universal precursor for various other high-value compounds. The important regulatory and rate-limiting role of acetyl-CoA carboxylase makes this enzyme a powerful tool in a variety of biotechnological and medical projects. This review presents the current knowledge on structural and functional features of the enzyme and focuses on its divergent applications. Different metabolic engineering attempts that lead to the production of various compounds, such as fatty acids, polyketides or flavonoids, are presented and their advantages and limitations discussed. The importance of studies on acetyl-CoA carboxylase activity for design and development of new herbicides and antibiotics as well as for medical intervention is also highlighted.
- Open Access
- 1 January 2011
- Published by Termedia Sp. z.o.o. in BioTechnologia
- Vol. 92 (2) , 119-131
PERSPECTIVESHigh throughput protein production
Research in the relationship between the architecture and function of proteins aims to understand the mechanism of proteins folding and their activity at the atomic level. This knowledge leads to a progress in new technologies that allow simultaneous production of numerous proteins on a large scale – high throughput protein production (HTPP) methods. The HTPP methods allow parallel processing of multiple samples and are also important for the determination of optimal protein production procedure, where usually combinations of different conditions have to be tested. This article describes available cloning, expression, and purification approaches that may be used in a high throughput and parallel manner. Additionally, the implementation of automation facilities is briefly outlined.
- 1 January 2011
- Published by Termedia Sp. z.o.o. in BioTechnologia
- Vol. 92 (2) , 119-131
Open AccessPERSPECTIVESHigh throughput protein production
Research in the relationship between the architecture and function of proteins aims to understand the mechanism of proteins folding and their activity at the atomic level. This knowledge leads to a progress in new technologies that allow simultaneous production of numerous proteins on a large scale – high throughput protein production (HTPP) methods. The HTPP methods allow parallel processing of multiple samples and are also important for the determination of optimal protein production procedure, where usually combinations of different conditions have to be tested. This article describes available cloning, expression, and purification approaches that may be used in a high throughput and parallel manner. Additionally, the implementation of automation facilities is briefly outlined.